EditorialDoes ARUBA study improve our knowledge as regards the management of unruptured brain arteriovenous malformations?L’étude ARUBA améliore-t-elle nos connaissances de la gestion des malformations artérioveineuses cérébrales non rompues ?
Section snippets
Disclosure of interest
The authors declare that they have no conflicts of interest concerning this article.
References (19)
- et al.
Angioarchitectural characteristics of brain arteriovenous malformations with and without hemorrhage
World Neurosurg
(2011) - et al.
Unruptured intracranial aneurysms: natural history, clinical outcome, and risks of surgical and endovascular treatment
Lancet
(2003) - et al.
Risk of recurrent subarachnoid haemorrhage, death, or dependence and standardised mortality ratios after clipping or coiling of an intracranial aneurysm in the International Subarachnoid Aneurysm Trial (ISAT): long-term follow-up
Lancet Neurol
(2009) - et al.
Long-term excess mortality in 623 patients with brain arteriovenous malformations
Neurosurgery
(2008) - et al.
The natural history and predictive features of hemorrhage from brain arteriovenous malformations
Stroke
(2009) - et al.
Risk of hemorrhage in patients with untreated Spetzler-Martin grade IV and V arteriovenous malformations: a long-term follow-up study in 63 patients
Neurosurgery
(2011) - et al.
Predictors of hemorrhage in patients with untreated brain arteriovenous malformation
Neurology
(2006) - et al.
Treatment guidelines for cerebral arteriovenous malformation microsurgery
Br J Neurosurg
(2009) - et al.
The ARUBA trial: current status, future hopes
Stroke
(2010)
There are more references available in the full text version of this article.
Cited by (0)
Copyright © 2014 Elsevier Masson SAS. All rights reserved.